When Sarah told her elderly mother about what she had found, she was horrified to hear that James had also been sexually ...

GSK is taking to the airwaves to get the message out about respiratory syncytial virus (RSV), presenting a TV special about how the pathogen has affected athletes in the upcoming National Senior Games ...

GSK’s Blenrep (belantamab mafodotin) combinations have been approved by the European Commission (EC) to treat adults with relapsed or refractory multiple myeloma.

The move underscores Meta’s strategy of spending aggressively now to secure a dominant position in what it views as the next foundational technology platform.

European Union approves GSK’s Blenrep combinations to treat relapsed/refractory multiple myeloma: London, UK Saturday, July 26, 2025, 11:00 Hrs [IST] GSK plc announced the appro ...

Jaina Patel was in her early 30s when a bout of bronchitis led to hear losing weight, her job and eventually her sense of smell - until a clinical trial worked wonders ...

Discover MarketSmith India's recommended stocks for 25 July. Get insights into top-performing stocks and make informed ...

Shares of health coverage company Centene (NYSE:CNC) jumped 5.9% in the afternoon session after the company reported ...

European regulators on Friday said that the Duchenne muscular dystrophy gene therapy Elevidys should not be approved ...

Thinking-2507, as we'll call it for short, now leads or closely trails top-performing models across several major benchmarks.

SEDA Experts LLC, a leading expert witness firm providing world-class financial expert witness services, announced today that ...

The FTSE 100 ended a six-day winning streak to close a strong week on the back foot, ahead of pending US trade talk deadlines ...